Enhabit Inc. (EHAB) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target
Enhabit Inc. stock (EHAB) is currently trading at $13.67. Enhabit Inc. PS ratio (Price-to-Sales) is 0.65. Analyst consensus price target for EHAB is $13.80. WallStSmart rates EHAB as Underperform.
- EHAB PE ratio analysis and historical PE chart
- EHAB PS ratio (Price-to-Sales) history and trend
- EHAB intrinsic value — DCF, Graham Number, EPV models
- EHAB stock price prediction 2025 2026 2027 2028 2029 2030
- EHAB fair value vs current price
- EHAB insider transactions and insider buying
- Is EHAB undervalued or overvalued?
- Enhabit Inc. financial analysis — revenue, earnings, cash flow
- EHAB Piotroski F-Score and Altman Z-Score
- EHAB analyst price target and Smart Rating
Enhabit Inc.
📊 No data available
Try selecting a different time range
Smart Analysis
Enhabit Inc. (EHAB) · 9 metrics scored
Smart Score
Category Performance
WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.
Investment Thesis
Strong fundamentals in price/sales, price/book, eps growth. Concerns around return on equity and operating margin. Mixed signals suggest waiting for clearer direction before acting.
Enhabit Inc. (EHAB) Key Strengths (4)
Paying less than $1 for every $1 of annual revenue
Earnings per share surging 8667.00% year-over-year
99.69% of shares held by major funds and institutions
Trading at 1.29x book value, attractively priced
Supporting Valuation Data
Enhabit Inc. (EHAB) Areas to Watch (5)
Company is destroying shareholder value
Company is losing money with a negative profit margin
Very thin margins with limited operational efficiency
Revenue growing slowly at 4.70% annually
Small-cap company with higher risk but more growth potential
Enhabit Inc. (EHAB) Detailed Analysis Report
Overall Assessment
This company scores 48/100 in our Smart Analysis, earning a D+ grade. Out of 9 metrics analyzed, 4 register as strengths (avg 9.5/10) while 5 fall into concern territory (avg 1.8/10). The category breakdown reveals uneven performance, with some areas requiring attention.
The Bull Case
The strongest argument centers on Price/Sales, EPS Growth, Institutional Own.. Valuation metrics including Price/Sales (0.65), Price/Book (1.29) suggest the stock is attractively priced. Growth metrics are encouraging with EPS Growth at 8667.00%.
The Bear Case
The primary concerns are Return on Equity, Profit Margin, Operating Margin. Growth concerns include Revenue Growth at 4.70%, which may limit upside. Profitability pressure is visible in Return on Equity at -0.47%, Operating Margin at 5.33%, Profit Margin at -0.43%.
Key Dynamics to Monitor
Three factors to monitor going forward. First, whether Return on Equity improves, as this is the primary drag on the overall score. Second, margin trajectory, with Return on Equity at -0.47% needing improvement to support the investment thesis. Third, growth sustainability, with Revenue Growth at 4.70% needing to reaccelerate.
Risk Considerations
Based on the metric profile, this is a higher risk investment. There are more areas of concern than strength, warranting a more conservative position size. Investors should size positions according to their risk tolerance and maintain diversification.
Bottom Line
Fundamental challenges outweigh strengths at current levels. Return on Equity and Profit Margin are the primary drags. Consider waiting for meaningful improvement before committing capital.
Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.
EHAB Price-to-Sales(PS) Ratio Chart
Historical valuation based on market cap ÷ trailing 12-month revenue
EHAB's Price-to-Sales ratio of 0.65x trades at a 23% premium to its historical average of 0.53x (80th percentile). The current valuation is 19% below its historical high of 0.8x set in Jul 2022, and 98% above its historical low of 0.33x in Jul 2025. Over the past 12 months, the PS ratio has expanded from ~0.4x, reflecting growing market expectations outpacing revenue growth.
Compare EHAB with Competitors
Top MEDICAL CARE FACILITIES stocks by market cap
Compare any two stocks →WallStSmart Analysis Synopsis
Data-driven financial summary for Enhabit Inc. (EHAB) · HEALTHCARE › MEDICAL CARE FACILITIES
The Big Picture
Enhabit Inc. is in a turnaround phase, with management focused on restoring profitability. Revenue reached 1.1B with 5% growth year-over-year. The company is currently unprofitable, posting a -0.4% profit margin.
Key Findings
Generating 3M in free cash flow and 4M in operating cash flow. Earnings are translating into actual cash generation.
The company is unprofitable with a -0.4% profit margin. The path to breakeven will be the key catalyst.
What to Watch Next
Debt management: total debt of 517M is significantly higher than cash (57M). Monitor refinancing risk.
Sector dynamics: monitor MEDICAL CARE FACILITIES industry trends, competitive moves, and regulatory changes that could impact Enhabit Inc..
Bottom Line
Enhabit Inc. is in turnaround mode. The path to profitability remains the critical question. Speculative investors may see opportunity in the recovery story, but conservative investors should wait for consistent positive earnings before committing capital.
This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.
Insider Transactions(55 last 3 months)
| Insider | Type | Shares |
|---|---|---|
MCQUIDDY, COLLIN Chief Accounting Officer | Sell | -1,403 |
| Insider | Type | Shares |
|---|---|---|
JOLLEY, JULIE DIANE EVP of Home Health Operations | Sell | -2,793 |
| Insider | Type | Shares |
|---|---|---|
JOLLEY, JULIE DIANE EVP of Home Health Operations | Sell | -2,793 |
Data sourced from SEC Form 4 filings
Last updated: 12:57:01 PM
About Enhabit Inc.(EHAB)
NYSE
HEALTHCARE
MEDICAL CARE FACILITIES
USA
Enhabit, Inc. provides home health and hospice services in the United States.